Akero Therapeutics, Inc.
Industry: Life Sciences ・ $AKRO on Nasdaq
Insider Sale
+$3,466,628
-15.18%
Shares
Shares Volume: 108,366 Shares
Average Share Price: $31.99
INSIDER
Cheng Andrew
President and CEO (Director)
reported on Nov 5 2024
traded on Nov 1 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 605,417 |
| PURCHASES/SALES 1Y | 0 / 7 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $1,386,987.92 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 2 |
| PURCHASES/SALES 1Y | 2 / 40 |
| P/S VALUE RATIO | 0.155 |
| AVERAGE SALE VALUE | $593,036.41 |
| COMPANY PREVIOUS TRADES |